You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 12, December 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

End-Stage Alzheimer's Disease

Glasgow Coma Scale and the Neurologic Examination

Curtis G. Benesch, MD; Keith D. McDaniel, MD; Christopher Cox, PhD; Robert W. Hamill, MD

Arch Neurol. 1993;50(12):1309-1315.


Abstract

Objective
To characterize the cognitive and neurologic features of patients with end-stage Alzheimer's disease using a standard neurologic examination and the Glasgow Coma Scale.

Design
Case series.

Setting
Local community nursing homes.

Patients
Forty patients with Alzheimer's disease were drawn from previously enrolled subjects in the Rochester Alzheimer's Disease Project with Clinical Dementia Rating scores of 3, 4, or 5.

Main Outcome Measures
Scores on the Glasgow Coma Scale and cognitive screening examinations and the prevalence of neurologic manifestations such as primitive reflexes and extrapyramidal signs were compared across the Clinical Dementia Rating groups.

Results
When compared with patients in the Clinical Dementia Rating stages 3 and 4, patients with a stage 5 scored significantly lower on the Glasgow Coma Scale, with the discriminating subscales being verbal and motor responses. Primitive reflexes, myoclonus, and dyskinesia were increasingly prevalent in the more terminal stages. Cognitive screening assessments did not discriminate between groups.

Conclusions
Rudimentary neurologic functions can be readily assessed and, when viewed together with the Glasgow Coma Scale, may circumvent the "floor effect" frequently encountered when using the currently available cognitive and functional scales and, thereby, better define patients with end-stage Alzheimer's disease.



Author Affiliations

From the Departments of Neurology (Drs Benesch, McDaniel, and Hamill), Psychiatry (Dr McDaniel), and Biostatistics (Dr Cox), University of Rochester (NY) School of Medicine and Dentistry. Dr Hamill is currently with the Department of Neurology, Medical Center Hospital of Vermont, Burlington.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Neurologic Examination in Adult Psychiatry: From Soft Signs to Hard Science
Sanders and Keshavan
J. Neuropsychiatry Clin. Neurosi. 1998;10:395-404.
ABSTRACT | FULL TEXT  

Neuropsychological Assessment of Severely Demented Elderly: The Severe Cognitive Impairment Profile
Peavy et al.
Arch Neurol 1996;53:367-372.
ABSTRACT  

End-Stage Alzheimer's Disease: Glasgow Coma Scale and the Neurologic Examination
Panisset et al.
Arch Neurol 1995;52:127-128.
ABSTRACT  

End-Stage Alzheimer's Disease: Glasgow Coma Scale and the Neurologic Examination-Reply
Hamill et al.
Arch Neurol 1995;52:128-128.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.